世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
The global neutropenia treatment market size reached USD 16.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24 Billion by 2033, exhibiting a growth rate (CAGR) of 4.... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryThe global neutropenia treatment market size reached USD 16.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24 Billion by 2033, exhibiting a growth rate (CAGR) of 4.7% during 2025-2033. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells. Neutropenia Treatment Market Trends: The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each segment of the global neutropenia treatment market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on treatment and distribution channel. Treatment Insights: Colony-Stimulating Factors Antibiotics Antifungals Antivirals The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the treatment. This includes colony-stimulating factors, antibiotics, antifungals and antivirals. According to the report, colony-stimulating factors represented the largest segment. Distribution channel Insights: Hospital Pharmacies Retail Pharmacies Online Pharmacies The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the distribution channel. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies represented the largest segment. Regional Insights: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements. Competitive Landscape: The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. Key Questions Answered in This Report 1. How big is the global neutropenia treatment market? 2. What is the expected growth rate of the global neutropenia treatment market during 2025-2033? 3. What are the key factors driving the global neutropenia treatment market? 4. What has been the impact of COVID-19 on the global neutropenia treatment market? 5. What is the breakup of the global neutropenia treatment market based on the treatment? 6. What is the breakup of the global neutropenia treatment market based on the distribution channel? 7. What are the key regions in the global neutropenia treatment market? 8. Who are the key players/companies in the global neutropenia treatment market? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Neutropenia Treatment Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Treatment 6.1 Colony-Stimulating Factors 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Antibiotics 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Antifungals 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Antivirals 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Distribution Channel 7.1 Hospital Pharmacies 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Retail Pharmacies 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Online Pharmacies 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 Drivers, Restraints, and Opportunities 9.1 Overview 9.2 Drivers 9.3 Restraints 9.4 Opportunities 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Amgen Inc. 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 BeyondSpring Inc. 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited) 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 Financials 13.3.3.4 SWOT Analysis 13.3.4 Pfizer Inc. 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.4.4 SWOT Analysis 13.3.5 Sandoz Inc. (Novartis AG) 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 SWOT Analysis 13.3.6 Spectrum Pharmaceuticals Inc. 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 Teva Pharmaceutical Industries Ltd. 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Viatris Inc. 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. List of Figures Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion USD), 2019-2024 Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033 Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2024 Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2024 Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2024 Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million USD), 2019 & 2024 Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024 Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million USD), 2019 & 2024 Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million USD), 2019 & 2024 Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024 Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024 Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024 Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024 Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2024 Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2024 & 2033 Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million USD), 2025-2033 Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033 Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033 Table 5: Global: Neutropenia Treatment Market: Competitive Structure Table 6: Global: Neutropenia Treatment Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
IMARC Services Private Limited.社の医療分野での最新刊レポート
本レポートと同じKEY WORD（antibiotics）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
